Multilaboratory Testing of Antifungal Drug Combinations against Candida Species and Aspergillus fumigatus: Utility of 100 Percent Inhibition as the Endpoint

被引:7
|
作者
Ren, Ping [1 ]
Luo, Ming [2 ]
Lin, Shao [2 ]
Ghannoum, Mahmoud A. [3 ,4 ]
Isham, Nancy [3 ,4 ]
Diekema, Dan J. [5 ]
Pfaller, Michael A. [5 ]
Messer, Shawn [5 ]
Lockhart, Shawn R. [6 ]
Iqbal, Naureen [6 ]
Chaturvedi, Vishnu [1 ]
机构
[1] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12208 USA
[2] New York State Dept Hlth, Bur Environm & Occupat Epidemiol, Albany, NY USA
[3] Case Western Reserve Univ, Ctr Med Mycol, Cleveland, OH 44106 USA
[4] Univ Hosp Case Med Ctr, Cleveland, OH USA
[5] Univ Iowa, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
[6] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA
关键词
INVASIVE FUNGAL-INFECTIONS; FIXED-DOSE COMBINATION; THERAPY; SURVEILLANCE; RIFAMPICIN;
D O I
10.1128/AAC.04545-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Four laboratories tested three isolates of Candida species and two isolates of Aspergillus fumigatus using 96-well plates containing combinations of amphotericin B, anidulafungin, caspofungin, micafungin, fluconazole, itraconazole, posaconazole, and voriconazole. The majority of summation fractional inhibitory concentration indices (Sigma FICI) based on the Lowe additivity formula suggested indifferent drug interactions (Sigma FICI > 0.5 and <= 4.0) and no instance of drug antagonism (Sigma FICI > 4.0). The intra-and interlaboratory agreement rates were superior when MIC100 readings were used as endpoints (at a 99% confidence interval [CI]).
引用
收藏
页码:1764 / 1771
页数:8
相关论文
共 7 条
  • [1] Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei
    Chaturvedi, Vishnu
    Ramani, Rama
    Ghannoum, Mahmoud A.
    Killian, Scott B.
    Holliday, Nicole
    Knapp, Cindy
    Ostrosky-Zeichner, Luis
    Messer, Shawn A.
    Pfaller, Michael A.
    Iqbal, Naureen J.
    Arthington-Skaggs, Beth A.
    Vazquez, Jose A.
    Sein, Tin
    Rex, John H.
    Walsh, Thomas J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (04) : 1500 - 1502
  • [2] Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis
    Chaturvedi, Vishnu
    Ramani, Rama
    Andes, David
    Diekema, Daniel J.
    Pfaller, Michael A.
    Ghannoum, Mahmoud A.
    Knapp, Cindy
    Lockhart, Shawn R.
    Ostrosky-Zeichner, Luis
    Walsh, Thomas J.
    Marchillo, Karen
    Messer, Shawn
    Welshenbaugh, Amanda R.
    Bastulli, Cara
    Iqbal, Noreen
    Paetznick, Victor L.
    Rodriguez, Jose
    Sein, Tin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1543 - 1548
  • [3] Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus
    Bartizal, C
    Odds, FC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) : 2100 - 2107
  • [4] Antifungal Activity of Selenium Nanoparticles Synthesized by Bacillus species Msh-1 Against Aspergillus fumigatus and Candida albicans
    Shakibaie, Mojtaba
    Mohazab, Naser Salari
    Mousavi, Seyyed Amin Ayatollahi
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2015, 8 (09)
  • [5] In-vitro activity of D0870, a new triazole antifungal drug, in comparison with fluconazole and itraconazole against Aspergillus fumigatus and Candida krusei
    Venkateswarlu, K
    Denning, DW
    Kelly, SL
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (06) : 731 - 736
  • [6] Defining Fractional Inhibitory Concentration Index Cutoffs for Additive Interactions Based on Self-Drug Additive Combinations, Monte Carlo Simulation Analysis, and In Vitro-In Vivo Correlation Data for Antifungal Drug Combinations against Aspergillus fumigatus
    Meletiadis, Joseph
    Pournaras, Spyros
    Roilides, Emmanuel
    Walsh, Thomas J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (02) : 602 - 609
  • [7] Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values
    Melhem, Marcia S. C.
    Coelho, Vivian C.
    Fonseca, Claudia A.
    de Oliveira, Lidiane
    Bonfietti, Lucas X.
    Szeszs, Maria W.
    Magri, Marcello M. C.
    Dorneles, Francine S.
    Taguchi, Hideaki
    Moreira, Daniel V. S.
    Motta, Adriana L.
    Batista, Marjorie, V
    Kamei, Katsuhiko
    Shikanai-Yasuda, Maria A.
    PHARMACEUTICS, 2022, 14 (10)